TFAM and metabolic dysfunction-associated steatohepatitis: Similar to obese and T2DM patients [123], both NAFL and NASH patients present decreased mRNA expression of PGC-1α, TFAM and Nrf-1, whilst only NASH patients presented increased levels of JNK phosphorylation and decreased CAT activity in the liver [69].